Abstract | BACKGROUND: METHODS: RESULTS: The median follow-up time was 27 months (interquartile range: 22-33) and endpoints were all-cause mortality, re- infarction and heart failure. Even when adjusted for all baseline variables, increasing OPN was independently associated with increased all-cause mortality, and the combined endpoint, a linear increase in OPN of 10 µg/l, was associated with a hazard ratio (HR) of 1.05 (95% confidence interval (CI): 1.02-1.08; p = 0.002) for all-cause mortality and HR 1.03 (95%CI: 1.01-1.05; p = 0.047) for the combined endpoint. Importantly, OPN interacted with the predictive power of hsCRP, and the combination of high OPN levels and high hsCRP levels (>3 mg/l) were significantly associated with increased risk of all-cause mortality (HR: 2.32; CI: 1.51-3.58; p < 0.001), re- infarction (HR: 2.19; CI: 1.22-3.93; p = 0.006), heart failure (HR: 1.84; CI: 1.08-3.13; p = 0.025) and the combined endpoint (HR: 2.08; CI: 1.53-2.84; p < 0.001). CONCLUSIONS: In conclusion, a high OPN level, especially in combination with a high hsCRP level, was associated with poor long-term outcome in STEMI patients treated with pPCI.
|
Authors | Mette Bjerre, Sune H Pedersen, Rasmus Møgelvang, Søren Lindberg, Jan S Jensen, Søren Galatius, Allan Flyvbjerg |
Journal | European journal of preventive cardiology
(Eur J Prev Cardiol)
Vol. 20
Issue 6
Pg. 922-9
(Dec 2013)
ISSN: 2047-4881 [Electronic] England |
PMID | 23613225
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- SPP1 protein, human
- Osteopontin
- C-Reactive Protein
|
Topics |
- Aged
- Biomarkers
(blood)
- C-Reactive Protein
(analysis)
- Chi-Square Distribution
- Denmark
- Female
- Heart Failure
(etiology, mortality)
- Hospitals, High-Volume
- Humans
- Kaplan-Meier Estimate
- Linear Models
- Male
- Middle Aged
- Myocardial Infarction
(blood, diagnosis, mortality, therapy)
- Osteopontin
(blood)
- Percutaneous Coronary Intervention
(adverse effects, mortality)
- Predictive Value of Tests
- Proportional Hazards Models
- Prospective Studies
- Recurrence
- Registries
- Risk Factors
- Time Factors
- Treatment Outcome
- Up-Regulation
|